Found: 7
Select item for more details and to access through your institution.
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis.
- Published in:
- Respiratory Research, 2012, v. 13, n. 6, p. 1, doi. 10.1186/1465-9921-13-53
- By:
- Publication type:
- Article
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study.
- Published in:
- Inflammation Research, 2015, v. 64, n. 11, p. 903, doi. 10.1007/s00011-015-0873-2
- By:
- Publication type:
- Article
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article